Cargando…

Discovery of a bacterial peptide as a modulator of GLP-1 and metabolic disease

Early work in rodents highlighted the gut microbiota’s importance in metabolic disease, including Type II Diabetes Mellitus (T2DM) and obesity. Glucagon-like peptide-1 (GLP-1), an incretin secreted by L-cells lining the gastrointestinal epithelium, has important functions: promoting insulin secretio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomaro-Duchesneau, Catherine, LeValley, Stephanie L., Roeth, Daniel, Sun, Liang, Horrigan, Frank T., Kalkum, Markus, Hyser, Joseph M., Britton, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080827/ https://www.ncbi.nlm.nih.gov/pubmed/32188864 http://dx.doi.org/10.1038/s41598-020-61112-0

Ejemplares similares

Degradation of the Incretin Hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis Metalloprotease GelE
por: LeValley, Stephanie L., et al.
Publicado: (2020)

The Gut Microbiota and Human Health with an Emphasis on the Use of Microencapsulated Bacterial Cells
por: Prakash, Satya, et al.
Publicado: (2011)

Human Intestinal Enteroids With Inducible Neurogenin-3 Expression as a Novel Model of Gut Hormone Secretion
por: Chang-Graham, Alexandra L., et al.
Publicado: (2019)

Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions
por: Tomaro-Duchesneau, Catherine, et al.
Publicado: (2013)

Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 Favorably Modulates Gut Microbiota and Reduces Circulating Endotoxins in F344 Rats
por: Rodes, Laetitia, et al.
Publicado: (2014)

Fluorogenic Peptide Substrate for Quantification of Bacterial Enzyme Activities
por: Al-Abdullah, Ismail H., et al.
Publicado: (2017)

Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012)

Microgels Formed by Spontaneous Click Chemistries Utilizing Microfluidic Flow Focusing for Cargo Release in Response to Endogenous or Exogenous Stimuli
por: LeValley, Paige J., et al.
Publicado: (2022)

Gut microbiota: next frontier in understanding human health and development of biotherapeutics
por: Prakash, Satya, et al.
Publicado: (2011)

A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis
por: Malhotra, Meenakshi, et al.
Publicado: (2011)

Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
por: Malhotra, Meenakshi, et al.
Publicado: (2013)

Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1)
por: Ang, Richard, et al.
Publicado: (2018)

Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
por: Guo, Wanjun, et al.
Publicado: (2023)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Affinity selection of double-click triazole libraries for rapid discovery of allosteric modulators for GLP-1 receptor
por: Xin, Ye, et al.
Publicado: (2023)

Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis
por: Jin, Yue, et al.
Publicado: (2015)

Cholesterol Assimilation by Lactobacillus Probiotic Bacteria: An In Vitro Investigation
por: Tomaro-Duchesneau, Catherine, et al.
Publicado: (2014)

A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice
por: Hornigold, David C., et al.
Publicado: (2018)

Ultrastructural Study on Colocalization of Glucagon-Like Peptide (GLP)-1 with GLP-2 in Chicken Intestinal L-Cells
por: NISHIMURA, Kei, et al.
Publicado: (2013)

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
por: Helmstädter, Johanna, et al.
Publicado: (2021)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
por: Holst, Jens Juul
Publicado: (2019)

Computer-aided Discovery of Peptides that Specifically Attack Bacterial Biofilms
por: Haney, Evan F., et al.
Publicado: (2018)

A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis
por: Wang, Yuqing, et al.
Publicado: (2023)

The Role of the Bacterial Muramyl Dipeptide in the Regulation of GLP-1 and Glycemia
por: Williams, Laura, et al.
Publicado: (2020)

Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F(1)B Golden Syrian Hamsters
por: Bhathena, Jasmine, et al.
Publicado: (2013)

Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1
por: Niu, Xianli, et al.
Publicado: (2020)

The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
por: Chuong, Vicky, et al.
Publicado: (2023)

Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro Characterization
por: Tomaro-Duchesneau, Catherine, et al.
Publicado: (2012)

Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo
por: Fremaux, Juliette, et al.
Publicado: (2019)

Correction for Xin et al., Affinity selection of double-click triazole libraries for rapid discovery of allosteric modulators for GLP-1 receptor
Publicado: (2023)

Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?
por: Felber, Veronika Barbara, et al.
Publicado: (2021)

Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery
por: Mizera, Mikołaj, et al.
Publicado: (2021)

Viroporins
por: Hyser, Joseph M.
Publicado: (2015)

Conformational coupling in BK potassium channels
por: Horrigan, Frank T.
Publicado: (2012)

Discovery of peptide probes to modulate oxytocin-type receptors of insects
por: Keov, Peter, et al.
Publicado: (2018)

Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection()()
por: Ussher, John R., et al.
Publicado: (2014)

The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
por: Bae, Choon Sang, et al.
Publicado: (2017)

Serotonergic modulation of the activity of GLP-1 producing neurons in the nucleus of the solitary tract in mouse
por: Holt, Marie K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ck5o971072k6p987k070gmqsb3